Ruel C - Search Results

1

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083.

Somlo G, Frankel PH, Arun BK, Ma CX, Garcia AA, Cigler T, Cream LV, Harvey HA, Sparano JA, Nanda R, Chew HK, Moynihan TJ, Vahdat LT, Goetz MP, Beumer JH, Hurria A, Mortimer J, Piekarz R, Sand S, Herzog J, Van Tongeren LR, Ferry-Galow KV, Chen AP, Ruel C, Newman EM, Gandara DR, Weitzel JN. Somlo G, et al. Among authors: ruel c. Clin Cancer Res. 2017 Aug 1;23(15):4066-4076. doi: 10.1158/1078-0432.CCR-16-2714. Epub 2017 Mar 29. Clin Cancer Res. 2017. PMID: 28356425 Free PMC article. Clinical Trial.

2

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.

Lara PN Jr, Chee KG, Longmate J, Ruel C, Meyers FJ, Gray CR, Edwards RG, Gumerlock PH, Twardowski P, Doroshow JH, Gandara DR. Lara PN Jr, et al. Among authors: ruel c. Cancer. 2004 May 15;100(10):2125-31. doi: 10.1002/cncr.20228. Cancer. 2004. PMID: 15139054 Free article. Clinical Trial.

3

Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.

Sahebi F, Spielberger R, Kogut NM, Fung H, Falk PM, Parker P, Krishnan A, Rodriguez R, Nakamura R, Nademanee A, Popplewell L, Frankel P, Ruel C, Tin R, Ilieva P, Forman SJ, Somlo G. Sahebi F, et al. Among authors: ruel c. Bone Marrow Transplant. 2006 May;37(9):825-9. doi: 10.1038/sj.bmt.1705339. Bone Marrow Transplant. 2006. PMID: 16565743 Clinical Trial.

4

The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study.

Davies AM, Ruel C, Lara PN, Lau DH, Gumerlock PH, Bold R, Shibata S, Lenz HJ, Schenkein DP, Gandara DR. Davies AM, et al. Among authors: ruel c. J Thorac Oncol. 2008 Jan;3(1):68-74. doi: 10.1097/JTO.0b013e31815e8b88. J Thorac Oncol. 2008. PMID: 18166843 Free article. Clinical Trial.

5

Biologic markers of angiogenesis: circulating endothelial cells in patients with advanced malignancies treated on phase I protocol with metronomic chemotherapy and celecoxib.

Twardowski PW, Smith-Powell L, Carroll M, VanBalgooy J, Ruel C, Frankel P, Synold TW. Twardowski PW, et al. Among authors: ruel c. Cancer Invest. 2008 Feb;26(1):53-9. doi: 10.1080/07357900701681541. Cancer Invest. 2008. PMID: 18181046 Clinical Trial.

6

Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma.

Ramalingam SS, Belani CP, Ruel C, Frankel P, Gitlitz B, Koczywas M, Espinoza-Delgado I, Gandara D. Ramalingam SS, et al. Among authors: ruel c. J Thorac Oncol. 2009 Jan;4(1):97-101. doi: 10.1097/JTO.0b013e318191520c. J Thorac Oncol. 2009. PMID: 19096314 Free PMC article. Clinical Trial.

7

Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial.

Jo S, Juhasz A, Zhang K, Ruel C, Loera S, Wilczynski SP, Yen Y, Liu X, Ellenhorn J, Lim D, Paz B, Somlo G, Vora N, Shibata S. Jo S, et al. Among authors: ruel c. Anticancer Res. 2009 May;29(5):1467-74. Anticancer Res. 2009. PMID: 19443352 Free PMC article. Clinical Trial.

8

Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial.

Twardowski P, Stadler WM, Frankel P, Lara PN, Ruel C, Chatta G, Heath E, Quinn DI, Gandara DR. Twardowski P, et al. Among authors: ruel c. Urology. 2010 Oct;76(4):923-6. doi: 10.1016/j.urology.2010.04.025. Epub 2010 Jun 19. Urology. 2010. PMID: 20646741 Free PMC article. Clinical Trial.

9

Aflibercept (VEGF Trap) in inoperable stage III or stage iv melanoma of cutaneous or uveal origin.

Tarhini AA, Frankel P, Margolin KA, Christensen S, Ruel C, Shipe-Spotloe J, Gandara DR, Chen A, Kirkwood JM. Tarhini AA, et al. Among authors: ruel c. Clin Cancer Res. 2011 Oct 15;17(20):6574-81. doi: 10.1158/1078-0432.CCR-11-1463. Epub 2011 Aug 31. Clin Cancer Res. 2011. PMID: 21880788 Free PMC article. Clinical Trial.

10

A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer.

Somlo G, Martel CL, Lau SK, Frankel P, Ruel C, Gu L, Hurria A, Chung C, Luu T, Morgan R Jr, Leong L, Koczywas M, McNamara M, Russell CA, Kane SE. Somlo G, et al. Among authors: ruel c. Breast Cancer Res Treat. 2012 Feb;131(3):899-906. doi: 10.1007/s10549-011-1850-2. Epub 2011 Nov 1. Breast Cancer Res Treat. 2012. PMID: 22042372 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters